Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
- Substances:AnastrozoleCamizestrant+6
France- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to France86 clinical trials in Quimper, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma and lymphoma treatments, evaluating novel therapeutic combinations and maintenance strategies.
Studies are exploring combinations of targeted therapies with standard treatments to improve patient outcomes.
Groundbreaking research in lung cancer, prostate cancer, and colorectal cancer treatments, including targeted therapies and immunotherapy approaches.
Trials focus on personalized medicine approaches targeting specific genetic mutations.
Studies addressing chronic kidney disease and associated conditions, along with innovative treatments for autoimmune disorders.
Research aims to improve treatment outcomes and quality of life for patients with chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.